Hovione Farmaciencia Sa, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FLUTICASONE PROPIONATE, with a corresponding US DMF Number 16334.
Remarkably, this DMF maintains an Active status since its submission on December 20, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 15, 2013, and payment made on December 14, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II